Completed PHASE2 INTERVENTIONAL 2-arm NCT01274702

Visual Reconstitution Therapy After Optic Neuritis (VISION)

Sponsor: Beuth Hochschule für Technik Berlin

Conditions Multiple Sclerosis Optic Neuritis

Interventions Saccadic Eye Movement Training Visual Reconstitutions Therapy

Updated 8 times since 2017 Last updated: Jul 28, 2021 Started: May 31, 2010 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01274702, this PHASE2 trial focuses on Multiple Sclerosis and Optic Neuritis and remains completed. Sponsored by Beuth Hochschule für Technik Berlin, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Sep 2021 [monthly]

Completed PHASE2
May 2020 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Dec 2018 — May 2020 [monthly]

Completed PHASE2
Jun 2018 — Dec 2018 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beuth Hochschule für Technik Berlin
Friedemann Paul
NovaVision AG, Zentrum für Sehtherapie

Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany